Show All
June 2020, in San Diego, CA.
BlossomHill is incorporated in the state of Delaware.
BlossomHill’s corporate headquarters is located at 10255 Science Center Dr Suite 200, San Diego, CA 92121.
BlossomHill’s initial public offering (IPO) occurred on August 7, 2026.
BlossomHill’s fiscal year end is December 31.
BlossomHill is traded on the NASDAQ Global Select Market under the ticker symbol “BLSM”.
No, BlossomHill does not pay a dividend.
BlossomHill’s independent registered public accounting firm is Deloitte & Touche LLP.
BlossomHill’s legal counsel is Cooley LLP.
The transfer agent and registrar for the common stock is Computershare Trust Company.
SEC filings can be found on our SEC Filings page and on the SEC website.
You can reach the BlossomHill Investor Relations team via e-mail at ir@bhtherapeutics.com.
If your shares are held in your name, you must contact our transfer agent, Computershare Trust Company. If your shares are held in street name, you must contact your broker to update your address.
If you have misplaced your stock certificates, please contact our transfer agent, Computershare Trust Company. There may be a fee involved for replacing lost stock certificates.
You can find news releases in the Press Releases section and financial reports in the SEC Filings section within this investor relations website.